Detalles de la búsqueda
1.
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Lancet Infect Dis
; 23(3): 352-360, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273490
Resultados
1 -
1
de 1
1
Próxima >
>>